- Global Pharma News & Resources

EVERSANA Announces European Expansion with New Location in the United Kingdom

EVERSANA Announces European Expansion with New Location in the United Kingdom

London office supports regional client needs and growing local team


LONDON, ENGLAND — April 26, 2022 — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, has opened a new office in the heart of London’s Holborn district to serve the company’s growing client and team needs.


Located at 6 Kean Street, the spacious open-concept facility will be home to a rapidly increasing European team and serve as a destination to connect clients throughout Europe with EVERSANA’s growing commercialisation services.


Mike Ryan, Executive Vice President, EMEA, will be based at this office, which includes experts across EVERSANA’s commercialisation solutions, including global pricing, consulting, and medical communications.


“It’s our privilege to work with our clients across Europe – a region that continues to bring new innovations to market every day,” said Jim Lang, CEO, EVERSANA. “Our teams have operated from Europe for many decades. As our world begins to come together in person once again, our London location is all about collaboration with each other and those we serve.”


The new location further accelerates EVERSANA’s position across Europe which includes employees in 18 countries. The company has announced multiple commercialisation agreements with European-based partners and clients. In 2021, the company also announced the expansion of medical information and integrated compliance services across Europe.



EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit or connect through LinkedIn and Twitter.


Media Contacts:



Matt Braun

Director, Corporate Communications


Editor Details

Last Updated: 27-Apr-2022